Finance

Beta
Lists
007370:KOSDAQ
Jin Yang Pharmaceutical Co Ltd
₩4,030.00
-5.62%
(-240.00) 1D
Jun 1, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 007370...
Open
₩4,255
High
₩4,260
Low
₩4,030
Mkt. cap
56.96B
Avg. vol.
38.12K
Volume
75.67K
Dividend
3.72%
Quarterly dividend
₩37
Ex-dividend date
Dec 27, 2024
P/E ratio
2.48
52-wk high
₩6,890
52-wk low
₩4,030
EPS
₩1,625
Shares outstanding
14.13M
No. of employees
220
Open
₩4,255
High
₩4,260
Low
₩4,030
Mkt. cap
56.96B
Avg. vol.
38.12K
Volume
75.67K
Dividend
3.72%
Quarterly dividend
₩37
Ex-dividend date
Dec 27, 2024
P/E ratio
2.48
52-wk high
₩6,890
52-wk low
₩4,030
EPS
₩1,625
Shares outstanding
14.13M
No. of employees
220
News stories
From sources across the web
About Jin Yang Pharmaceutical Co Ltd
CEO-
Employees220
Founded1971
Headquarters-
SectorPharmaceutical industry
Websitejinyangpharm.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
30.18B
29.25B
30.32B
32.40B
Cost of goods sold
10.50B
10.16B
10.51B
10.88B
Cost of revenue
10.50B
10.16B
10.51B
10.88B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.56B
18.99B
21.33B
18.38B
Operating expense
17.20B
20.03B
22.67B
18.16B
Total operating expenses
27.71B
30.19B
33.17B
29.03B
Operating income
2.48B
-939.94M
-2.85B
3.37B
Other non operating income
8.56M
4.51M
-478.82M
423.99M
EBT including unusual items
1.97B
-1.46B
24.97B
2.92B
EBT excluding unusual items
1.90B
-1.47B
-3.93B
3.26B
Income tax expense
280.06M
-465.57M
5.65B
655.97M
Effective tax rate
14.25%
31.97%
22.61%
22.43%
Other operating expenses
12.08M
73.55M
477.16M
117.56M
Net income
1.69B
-990.83M
19.33B
2.27B
Net profit margin
5.58%
-3.39%
63.75%
7.00%
Earnings per share
-
-
-
-
Interest and investment income
2.38M
25.13M
-
8.97M
Interest expense
-581.18M
-560.86M
-596.09M
-548.77M
Net interest expenses
-578.80M
-535.73M
-596.09M
-539.80M
Depreciation and amortization charges
97.95M
88.66M
155.48M
156.72M
EBITDA
3.06B
-362.31M
-2.21B
4.00B
Gain or loss from assets sale
-30.00M
1.00K
29.00K
38.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer